文献速递冠心病外科

双联抗血小板治疗患者冠脉搭桥术后出血的血小板聚集检测预测价值

Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

该前瞻性研究纳入226例体外循环下孤立冠脉搭桥患者,术前用Multiplate分析仪行ADP和ASPI检测,评估双联抗血小板治疗类型、停药时间及聚集检测结果与术后出血的关系。结果显示总体出血无显著差异,但ADP检测结果可独立预测ASA+T组出血,ASPI检测预测ASA+C组出血。

要点

  • 术前血小板聚集检测有助于预测双联抗血小板治疗患者冠脉搭桥术后出血。
  • ADP检测结果可独立预测ASA+T组术后出血,ASPI检测预测ASA+C组。
  • 停药≥4天时ADP功能恢复比例更高,ASA+T组出血显著减少。

核心结论

  • 血小板聚集检测可帮助预测双联抗血小板治疗患者冠脉搭桥术后出血。

研究设计与样本

  • 前瞻性研究,纳入226例体外循环下孤立冠脉搭桥患者,术前用Multiplate分析仪行ADP和ASPI检测。

主要发现

  • 术后总出血量在ASA+C组与ASA+T组间无显著差异(6小时中位数:ASA+C=335 ml,ASA+T=300 ml,P=0.21)。
  • 停药间隔越长,两组ADP相关血小板功能正常率越高(ASA+C组P=0.04;ASA+T组P=0.006),但仅ASA+T组三个时间点出血量均显著更小。
  • ADP检测显示血小板功能恢复者中出血>450 ml(6小时)比例更低(ASA+T组P=0.002;ASA+C组P=0.053)。
  • ADP检测结果与出血量的相关性在ASA+T组更强(如6小时r=-0.6,P<0.001)。
  • 多变量分析中,ADP检测结果独立预测ASA+T组术后出血,ASPI检测独立预测ASA+C组术后出血。

临床怎么用

  • 对术前接受双联抗血小板治疗的冠脉搭桥患者,可考虑术前行血小板聚集检测以辅助预测术后出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We tested the possible value of routine aggregometry testing for bleeding prediction following coronary artery bypass grafting in patients who received preoperative double antiplatelet therapy. METHODS: In 226 patients undergoing on-pump isolated coronary artery bypass grafting, aggregometry [adenosine diphosphate (ADP) test and ASPI test] was always prospectively performed by Multiplate® analyser immediately before surgery. We assessed the differences in postoperative bleeding according to the type of double antiplatelet therapy [acetylsalicylic acid plus clopidogrel (ASA+C), or plus ticagrelor (ASA+T)], duration of clopidogrel/ticagrelor withdrawal (0-3 days or ≥ 4 days) and results of aggregometry tests. Multivariable predictors of blood losses were sought by linear regressions (drainage amount at 6, 12 and 24 postoperative hours) and logistic regression (increased bleeding: 75th percentile of blood losses at 6 h, i.e. >450 ml). RESULTS: Overall, postoperative blood losses did not significantly differ between treatment groups (median at 6 h: ASA + C = 335 ml, ASA + T = 300 ml, P = 0.21). With longer withdrawal interval, higher rates of patients with normal ADP-related platelet function were observed in both groups (ASA + C: P = 0.04; ASA + T: P = 0.006) but only in the ASA + T group were blood losses significantly smaller at all 3 time points. Bleeders (>450 ml at 6 h) were significantly less frequent among patients with ADP test showing recovered platelet function (ASA + T: P = 0.002; ASA + C: P = 0.053). The correlation between ADP test result and blood losses amount was stronger in the ASA + T group (e.g. at 6 h: r = -0.6; P < 0.001). In multivariable analyses, the ADP test result independently predicted postoperative bleeding in the ASA + T group and the ASPI test in the ASA + C group. CONCLUSIONS: Aggregometry can help in predicting postoperative bleeding in double antiplatelet therapy patients undergoing coronary artery bypass grafting.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Della Corte A, Bancone C, Spadafora A, et al. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry. Eur J Cardiothorac Surg. 2017. PMID: 28977378. doi:10.1093/ejcts/ezx181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。